Samsara BioCapital’s Kadmon Holdings, Inc. KDMN Stock Holding History

Samsara BioCapital’s Portfolio KDMN Stock Details KDMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-165,000	Closed	-$685	–	51
2020 Q4	$685	Buy	+165,000	New	+$651K	0.07%	40

Other funds holding KDMN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Third Point New York $2.08B AUM 27.04% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Samsara BioCapital's KDMN Position: Q1 2021 in Review

Samsara BioCapital sold out of Kadmon Holdings, Inc. (KDMN) in Q1 2021, closing a stake of 165,000 shares — an estimated $685 sold.

Samsara BioCapital first reported a position in KDMN in Q4 2020 and held it in 1 quarter. The position peaked at $685 in Q4 2020. 145 funds tracked by Wall St. Rank hold KDMN as of Q1 2021.

Samsara BioCapital reported no remaining Kadmon Holdings, Inc. position as of Q1 2021 after selling out during the quarter.
Samsara BioCapital sold 165,000 Kadmon Holdings, Inc. shares in Q1 2021, an estimated $685.
Samsara BioCapital first reported a position in Kadmon Holdings, Inc. in Q4 2020 and held it in 1 quarter.
Samsara BioCapital's Kadmon Holdings, Inc. position peaked at $685 in Q4 2020.
145 funds tracked by Wall St. Rank held Kadmon Holdings, Inc. as of Q1 2021.

Based on Samsara BioCapital's 13F filing for Q1 2021, filed 18 May 2021.